Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/12/2011
PIL Arixtra 2.5mg/0.5ml solution for injection, pre-filled syringe.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
Updated on 02/11/2011 and displayed until 23/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 06/06/2011 and displayed until 02/11/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 18/10/2010 and displayed until 06/06/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/10/2010 and displayed until 18/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 17/03/2009 and displayed until 05/10/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
Updated on 30/04/2008 and displayed until 17/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 23/10/2007 and displayed until 30/04/2008
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to how to administer the medicine
Updated on 26/06/2007 and displayed until 23/10/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 01/11/2005 and displayed until 26/06/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 02/06/2005 and displayed until 01/11/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  fondaparinux sodium